Shankar Musunuri, Ocugen CEO

Ocu­gen hits an­oth­er snag in bring­ing its Bharat Biotech-part­nered Covid-19 vac­cine to the US

Back in Ju­ly, Ocu­gen and Bharat Biotech un­veiled some Phase III da­ta sug­gest­ing their Covid-19 vac­cine, Co­v­ax­in, was 77.8% ef­fec­tive at pre­vent­ing over­all dis­ease in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA